Effects of 20% albumin infusion during liver transplantation on plasma NGAL concentration: prospective, randomized research

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004852

Enrollment

140

Registered

2020-03-24

Start date

2020-03-10

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : This research is a prospective research to verify the effect of 20% albumin on kidney injury in patients underwent liver transplantation. This study will enroll the patients who have agreed to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patient (over 19 years old) Preoperative blood albumin =4.0 g / dL

Exclusion criteria

Exclusion criteria: Patients suspected of elevated intracranial pressure due to hepatic encephalopathy

Design outcomes

Primary

Measure	Time frame
The differences in serum NGAL according to the administration of 20% albumin during liver transplantation	—

Secondary

Measure	Time frame
the difference of two groups in serum albumin concentration over time during the perioperative phase	—

Countries

Korea, Republic of

Contacts

Public ContactDoyeon Kim

Samsung Medical Center

kimdoyeon31@gmail.com+82-2-3410-2470

Outcome results